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Background: Rhodiola rosea L. root (Golden Root, Arctic Root) is a high-value herbal medicinal product, 
20
There are different species of Rhodiola on the market and the principal aim is to establish how these different 21 species vary in their metabolite profile, how products are commercialised and whether there is potential for 22 adulteration at the product manufacture stage.
23
Methods: Approximately 40 commercial products have been sourced from different suppliers. We analysed 24 these samples using high performance thin layer chromatography (HPTLC), mass spectrometry (MS) and 
88
The root of R. rosea is mainly wild-harvested, the main region being the Altai Mountains in southern Siberia 89 (Galambosi, 2005 
113

Aims and Objectives
114
To select a sample of Rhodiola products, available from the internet and from retail outlets and assess their 115 phytochemical composition.
116
To determine whether there are phytochemical differences between registered products and unregistered 117 products and to assess how this impacts on the products' quality (and thus on safety as well as consumer 118 confidence).
119
Materials and methods
120
Test samples
121
Approximately 40 products were obtained from different suppliers including retail outlets and products that 
128
A detailed description of all investigated products is provided in the supplementary data. 
159
Apparatus and instrumentation
160
The LC-MS/MS data was acquired with an Agilent 1100 HPLC system which was coupled to a Bruker Daltonics 164 column (2.1 x 150 mm, Silica 3µm) was used which was heated to 50°C.
165
Data reduction and multivariate statistics methods
166
The ¹H-NMR spectra were phase-corrected, baseline-corrected, and zeroed to the TMS peak. The spectra were 167 converted to an ASCII file using AMIX software for multivariate analysis. AMIX was used to generate a number 
187
The temperature and the relative humidity within the developing chamber (ADC2) were 23 ⁰ C and 33 % 188 respectively.
189
The derivatisation of plates was performed through dipping (Speed: 3, time:0) with 10 % sulphuric acid in 
197
Results and Discussion
198
The samples were analysed by ¹H-NMR spectroscopy coupled with SIMCA multivariate analysis software, mass 199 spectrometry and HPTLC.
200
In the ¹H-NMR spectroscopy analysis, the two main constituents of R. rosea root, salidroside and rosavin were (Fig. 1) . However, peaks corresponding to salidroside and rosavin could be observed in 210 the aromatic region of the spectrum (6.2-8.5 ppm) (Fig. 2) . Using this method we were able to confirm the 211 presence of both saldroside and rosavin in our samples.
213
Figure 2 ¹H-NMR spectra of R. rosea extract (top) together with spectra of reference standards of salidroside
214
(middle) and rosavin (bottom), respectively, focusing on aromatic region.
8
The PCA model for the ¹H-NMR spectroscopy (Fig. 3) , utilises data obtained for the entire spectral region (0 -216 10 ppm). The Rhodiola products PCA appeared to indicate that although there was much variation between 217 samples, the variation did not distinguish between the different species. The principal variation between these 218 two species is rosavin content.
220
Figure 3 Scores plot showing the whole spectral regions of investigated Rhodiola samples
221
The PCA grouping in Fig. 3 
246
S2 displayed a strong zone at R F 0.92, S13 displayed brightly coloured greenish zones (R F 0.3 and 0.4) S8 247 appeared not to contain any compounds detectable under this system.
248
After discovering that these seven samples were adulterated either with other Rhodiola species or unknown 249 species, it was possible for us to re-label the assigned samples in the NMR -PCA.
250
Once re-labelled, the PCA displayed an improved differentiation between the R. rosea and Rhodiola crenulata 251 samples (Fig. 5) . Although we have re-labelled five of the products that did not contain rosavins as R. crenulata 252 it should be recognised that these may be adulterated with other Rhodiola species and we are currently 
274
One of the problematic factors in the metabolomic analysis of commercial products is the presence of 275 excipients. These tend to occur within the carbohydrate region and, in order to minimise the effect of any 276 excipient, we performed a PCA exclusively on the aromatic region (7 -10ppm).
277
In order to compare only the aqueous and hydro-ethanolic extract products, the crude raw drugs (samples 1, 278 34 and 35) were removed from the data set, together with the unknown products (samples 8 and 13) and a 279 soft-gel extract (sample 28). The resulting PCA showed a better differentiation between R. rosea and the non-280 rosea species. Further investigations will determine whether these are R. crenulata or other adulterant
281
Rhodiola species (Fig. 8) .
282
It is observed that the products that are highest in rosavin are in the bottom right quadrant. There is a group of 283 seven products that are higher in rosavin content than other products, including the 2 THR products (11 and 284 33). However, there are some R. rosea products that appear to have a very low rosavin content; in fact the PCA 285 places these more closely to the group we have labelled R. crenulata products (samples 5 and 6). 
